Regional media highlights UC pancreatic cancer vaccine trial
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
Davendra Sohal, MD, site principal investigator, said this trial builds on the same mRNA technology that was used to develop vaccines for COVID-19.
"In addition to the standard surgery and chemotherapy, they also get this very personalized vaccine created using their own tumor profile,” Sohal, associate director for clinical research at the Cancer Center and professor of internal medicine in UC’s College of Medicine, told Local 12.
The vaccine is developed in about four to six weeks while patients are recovering from surgery, and patients are then given six weekly injections of the vaccine. Following six months of standard chemotherapy, patients then receive six more vaccine injections as boosters.
In the Phase 1 trial, Sohal said eight out of 32 patients were completely cured of their cancer.
Watch or read the Local 12 story.
Read the Becker's Hospital Review story.
Read the WDRB Louisville story.
For more information on the trial, please call 513-584-7698 or email cancer@uchealth.com.
Featured photo at top of a vaccine being administered. Photo/National Cancer Institute/Unsplash.
Related Stories
Putting preschool into perspective
July 20, 2026
Preschool and childcare can be difficult to navigate for parents, as Spectrum News 1 Ohio recently reported. Waitlists are long, and factors like cost, location and transportation can limit options. According to a recent study published by The Annie E. Casey Foundation, only 41% of 3- to 4-year-olds in Ohio were enrolled in preschool between 2020 and 2024 — a 4% decrease from pre-pandemic numbers. For University of Cincinnati early childhood education faculty member Chad Nunamaker, that statistic has caveats.
Engineering magnets for a cleaner future
July 20, 2026
The United States is heavily reliant on imported rare-earth materials to make permanent magnets. Ugochukwu Philip Ochieze, materials science student at the University of Cincinnati, is studying how to use common materials to create permanent magnets, eliminating the need for expensive and scarce rare-earth materials. Pursuing his PhD, Ochieze was named Graduate Student Engineer of the Month by the College of Engineering and Applied Science.
Ticks that survive pesticides can withstand colder winters
July 17, 2026
Ticks that survive less-than-lethal doses of pesticide are able to withstand dangerous cold, which could help them expand their range farther north, according to researchers at the University of Cincinnati and the U.S. Department of Agriculture.